Past Events Past Events Past Events Mar 13, 2024 at 10:00 AM EDT Leerink Partners Global Biopharma Conference Listen to webcast Feb 12, 2024 at 8:00 AM EST Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia Click Here for Webcast
Past Events Past Events Mar 13, 2024 at 10:00 AM EDT Leerink Partners Global Biopharma Conference Listen to webcast Feb 12, 2024 at 8:00 AM EST Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia Click Here for Webcast
Feb 12, 2024 at 8:00 AM EST Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia Click Here for Webcast